FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
30,005,418
Share change
-1,262,273
Total reported value
$107,116,199
Put/Call ratio
61%
Price per share
$3.57
Number of holders
81
Value change
-$4,495,832
Number of buys
35
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q2 2021

As of 30 Jun 2021, FORTRESS BIOTECH INC - COM (FBIO) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,005,418 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Opaleye Management Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, SHIKIAR ASSET MANAGEMENT INC, CPWM, LLC, and MORGAN STANLEY. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.